{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:12:03Z","timestamp":1789132323999,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\n Objective:<\/jats:title>\n Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder that affects women during their reproductive age, which may cause infertility. Probiotics may be effective in PCOS by affecting the gut microbiota. We aimed to evaluate the effect of probiotic supplementation on metabolic parameters and androgen levels in women with PCOS.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n This double-blind, randomized clinical trial was performed on 84 patients aged 18\u201345 years with PCOS. Participants were randomly assigned to two groups and received probiotics (\n Saccharomyces boulardii<\/jats:italic>\n ) or a matched placebo for 3 months. Anthropometric parameters, including body mass index (BMI), waist circumference, and abdominal circumference, were assessed at baseline and after 12 weeks for all patients. Fasting blood samples were collected before and after the intervention to assess fasting blood sugar (FBS), dehydroepiandrosterone sulfate (DHEA-S), and testosterone levels.\n <\/jats:p>\n <\/jats:sec>\n \n Finding:<\/jats:title>\n \n Probiotic supplementation significantly decreased testosterone hormone level (\n P<\/jats:italic>\n = 0.0029) and DHEA-S level (\n P<\/jats:italic>\n = 0.0031) compared to the placebo group. The reduction in the BMI and FBS parameters in the intervention group was significant within the group, but the between-groups difference was not significant. Also, intragroup analysis in the placebo group revealed no significant differences in BMI, FBS, testosterone, or DHEA-S levels before and after the intervention.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n \n Overall, probiotic supplementation of\n S. boulardii<\/jats:italic>\n in PCOS women did not affect weight, BMI, or FBS but reduced testosterone and DHEA-S levels. Therefore,\n S. boulardii<\/jats:italic>\n probiotics might be beneficial in the management of PCOS patients.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jrpp.jrpp_90_25","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:00:17Z","timestamp":1787922017000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Supplementation with Saccharomyces boulardii in Women with Polycystic Ovary Syndrome: A Double-blind, Randomized Controlled Trial"],"prefix":"10.4103","volume":"15","author":[{"given":"Fariba","family":"Pourkarim","sequence":"first","affiliation":[{"name":"Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"},{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Khani","sequence":"additional","affiliation":[{"name":"Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"},{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobra","family":"Hamdi","sequence":"additional","affiliation":[{"name":"Women\u2019s Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Soroush-Oskoui","sequence":"additional","affiliation":[{"name":"Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Sarbakhsh","sequence":"additional","affiliation":[{"name":"Department of Statistics and Epidemiology, School of Public Health, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mastaneh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Shaseb","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran"},{"name":"Women\u2019s Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7]]},"reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2018.03.007","article-title":"Serum AMH levels and insulin resistance in women with PCOS","volume":"224","author":"Sahmay","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1507\/endocrj.EJ19-0004","article-title":"Long non-coding RNA H19 is associated with polycystic ovary syndrome in Chinese women: A preliminary study","volume":"66","author":"Qin","year":"2019","journal-title":"Endocr J"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","article-title":"Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome","volume":"18","author":"Hart","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00508-009-1162-2","article-title":"Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome","volume":"121","author":"Wehr","year":"2009","journal-title":"Wien Klin Wochenschr"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the polycystic ovary syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5152\/jtgga.2012.39","article-title":"Health related quality of life among different PCOS phenotypes of infertile women","volume":"13","author":"Dilbaz","year":"2012","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1479-828X.2012.01448.x","article-title":"The treatment of infertility in polycystic ovary syndrome: A brief update","volume":"52","author":"Costello","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/2042018812437355","article-title":"The effects of old, new and emerging medicines on metabolic aberrations in PCOS","volume":"3","author":"Bargiota","year":"2012","journal-title":"Ther Adv Endocrinol Metab"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/MPG.0b013e318263066c","article-title":"Probiotics to adolescents with obesity: Effects on inflammation and metabolic syndrome","volume":"55","author":"G\u00f8bel","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ejcn.2012.103","article-title":"The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: An open label, randomized pilot study","volume":"66","author":"Leber","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"e01011","DOI":"10.1128\/mBio.01011-14","article-title":"Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db\/db mice","volume":"5","author":"Everard","year":"2014","journal-title":"mBio"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3920\/BM2019.0056","article-title":"Saccharomyces boulardii Tht 500101 changes gut microbiota and ameliorates hyperglycaemia, dyslipidaemia, and liver inflammation in streptozotocin-diabetic mice","volume":"10","author":"Albuquerque","year":"2019","journal-title":"Benef Microbes"},{"key":"R18-20260911","first-page":"230","article-title":"Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children","volume":"16","author":"Zhao","year":"2014","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1651-2227.2008.00977.x","article-title":"A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children","volume":"98","author":"Hurduc","year":"2009","journal-title":"Acta Paediatr"},{"key":"R20-20260911","first-page":"S99","article-title":"The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H. pylori: A randomized controlled trial","volume":"6","author":"Zojaji","year":"2013","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.5897\/AJPP12.400","article-title":"Intervention study on Saccharomyces boulardii with proton pump inhibitor (PPI)-based triple therapy for Helicobacter pylori related peptic ulcer","volume":"6","author":"Chu","year":"2012","journal-title":"Afri J Pharm Pharmacol"},{"key":"R22-20260911","first-page":"555","article-title":"Therapeutic effect of Saccharomyces boulardii combined with standard triple therapy for Helicobacter pylori eradication","volume":"17","author":"Gao","year":"2012","journal-title":"Chin J Gastroenterol"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of gut microbiota (DOGMA)-a novel theory for the development of polycystic ovarian syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med Hypotheses"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13048-019-0480-x","article-title":"Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome","volume":"12","author":"Ostadmohammadi","year":"2019","journal-title":"J Ovarian Res"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"105203","DOI":"10.1016\/j.jff.2022.105203","article-title":"Effects of probiotic supplementation on hormonal and clinical outcomes of women diagnosed with polycystic ovary syndrome: A double-blind, randomized, placebo-controlled clinical trial","volume":"96","author":"Arab","year":"2022","journal-title":"J Funct Foods"},{"key":"R26-20260911","first-page":"1","article-title":"Effects of probiotic supplementation on hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial","volume":"21","author":"Karamali","year":"2018","journal-title":"Arch Iran Med"},{"key":"R27-20260911","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2008-7802.153866","article-title":"Effects of probiotic supplementation on pancreatic \u03b2-cell function and C-reactive protein in women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial","volume":"6","author":"Shoaei","year":"2015","journal-title":"Int J Prev Med"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/nu13082512","article-title":"Effects of 60-day Saccharomyces boulardii and superoxide dismutase supplementation on body composition, hunger sensation, pro\/antioxidant ratio, inflammation and hormonal lipo-metabolic biomarkers in obese adults: A double-blind, placebo-controlled trial","volume":"13","author":"Rondanelli","year":"2021","journal-title":"Nutrients"},{"key":"R29-20260911","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.3390\/nu15143144","article-title":"Probiotics and polycystic ovary syndrome: A perspective for management in adolescents with obesity","volume":"15","author":"Calcaterra","year":"2023","journal-title":"Nutrients"},{"key":"R30-20260911","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.3390\/ijms241512015","article-title":"Investigating the efficacy of Saccharomyces boulardii in metabolic syndrome treatment: A narrative review of what is known so far","volume":"24","author":"Egea","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Research in Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_90_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:01:11Z","timestamp":1789131671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrpp.jrpp_90_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jrpp.jrpp_90_25","relation":{},"ISSN":["2319-9644","2279-042X"],"issn-type":[{"value":"2319-9644","type":"print"},{"value":"2279-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-11-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}